Recruiting now—All ages

Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project

Sponsor: Istituto Ortopedico Rizzoli · NCT05357768 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Undifferentiated Round Cell Sarcoma

What it tests

data collection and analysis on Formalin-fixed paraffin embedded tissue and/or frozen tumoral tissueother

Where it's running1 site

1 international site

IRCCs Istituto Ortopedico Rizzoli
Bologna, BO, Italy 40136
Recruiting now
- Emanuela Palmerini, MD(contact)051.63.66 [email protected]
- Emanuela Palmerini, MD(principal investigator)

See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Patients with undifferentiated round cell sarcomas treated from 01 January 1983 and all new patients will be included.
* Clinical and outcome information available.
* Histological slides/formalin-fixed paraffin-embedded tissue tumor blocks from archive available to perform the histology analysis/frozen tissue representative of the tumor available.

Exclusion Criteria:

* Diagnosis different from undifferentiated round cell sarcomas
* Patient with no clinical or outcome information available

Updated 2025-05-30 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.